Houston, TX – According to filings with the U.S. Securities and Exchange Commission, Saranas is raising $20,508,704.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, James Reinstein played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Saranas
Saranas is a privately held Houston-based medical device company focused on improving patient outcomes through early detection and monitoring of internal bleeding complications. The companys patented Early Bird Bleed Monitoring System for vascular access procedures enables physicians to mitigate downstream consequences by addressing bleeding complications immediately, improving patient outcomes and lowering healthcare costs.

To learn more about Saranas, visit http://saranas.com/

Contact:
James Reinstein, President and Chief Executive Officer
833-375-9273
https://www.linkedin.com/in/james-reinstein-7755a634/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved